← Leaderboards
Ludmila Belayev
Inotek Pharmaceuticals Corporation
$1,038,850
Attributed
$1,038,850
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$1,038,850 · 1
By mechanism
R44$1,038,850 · 1
Top collaborators
No co-investigators on record.
Most similar at Inotek Pharmaceuticals Corporation
Same institution · by research overlap
- Csaba Szabo$15,264,870
- Garry John Southan$13,828,224
- Andrew L Salzman$19,918,828
- Prakash Jagtap$6,029,479
- Kanneganti Murthy$5,565,701
Others in their field
Top investigators on “Adenine Phosphoribosyltransferase”
- Joseph A. Baur · University Of Pennsylvania$4,522,091
- Joe G. N. Garcia · University Of Florida$3,907,347
- Buddy Ullman · Oregon Health And Science University$3,668,403
- Shinghua Ding · University Of Missouri-Columbia$3,486,897
- Gregory R J Thatcher · University Of Arizona$2,264,368
- Albert Hong-Jae Kim · Boston Children'S Hospital$2,120,468
Research focus
Adenine PhosphoribosyltransferaseAntiinflammatory AgentsCardiovascular AgentsCardiovascular Disorder ChemotherapyClinical Trial Phase ICytoprotectionDrug Design /Synthesis /ProductionDrug Screening /EvaluationEnzyme InhibitorsHemodynamicsHuman SubjectHuman Therapy EvaluationLaboratory MouseNitric OxideNonhuman Therapy EvaluationPatient Oriented ResearchPentosyltransferasePharmacokineticsSeptic ShockSwine